Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial: Extended Follow-up Study

Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting Stent Trial: Extended Follow-up Study - RESET:Extended Follow-up Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030732

Enrollment

3196

Registered

2018-02-02

Start date

2018-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 3196 patients who participated in the RESET trial.

Exclusion criteria

Exclusion criteria: Patients who refuse to participate.

Design outcomes

Primary

Measure	Time frame
Any TLR A composite of all-cause death and MI	—

Countries

Japan

Contacts

Public ContactHiroki Shiomi

Kyoto University Graduate School of Medicine Department of Cardiovascular Medicine

hishiomi@kuhp.kyoto-u.ac.jp075-751-4255

Outcome results